001065.KO JW Pharmaceutical Corp

Healthcare Pharmaceuticals Korea Stock Exchange
32,250 KRW
Close of Nov 4, 2026
19,710 29,530
Market cap
KRW 648B
P/E
-
P/B
-
ROE
27.0%
Dividend yield
1.71%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 001065.KO undervalued?

Graham number

The Graham number of JW Pharmaceutical Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

JW Pharmaceutical Corp fundamental analysis

No fundamental analysis for JW Pharmaceutical Corp yet.

JW Pharmaceutical Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About JW Pharmaceutical Corp

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases, and pancreatic cancer. The company also provides infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and b…

Full company profile